Averion Inc. and SIPLAS Research Organization Inc. Sign Alliance Agreement for Complementary Promotion and Support of Clinical Trials.FRAMINGHAM, Mass. & BOGOTA, Colombia -- Averion Inc. (Averion) a leading Contract Research Organization with more than 20 years experience, announced today that it has signed a non-exclusive alliance agreement with SIPLAS Research Organization Inc. (SIPLAS RO). SIPLAS RO is a full-service Contract Research Organization, which provides Phase II-IV services for clinical trials conducted in Latin America Latin America, the Spanish-speaking, Portuguese-speaking, and French-speaking countries (except Canada) of North America, South America, Central America, and the West Indies. . This agreement represents a working relationship that will involve joint marketing efforts and a mutual contracting of complementary products and services from both companies to biotechnology, pharmaceutical and medical device companies. Among the areas where a partnership would appear to be beneficial to both parties are cases when Averion may wish to conduct multi-national studies including Latin America or when SIPLAS RO may wish to conduct multi-national studies including North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. . "We are very excited about this alliance with SIPLAS RO," said Brian Langin, Averion's Associate Director of Business Development and Strategic Alliances. "We now have the ability to offer our clients the assurance of a Latin American partner who has the same level of quality, integrity and commitment that Averion is recognized for." "The alliance with Averion brings us a depth of operational experience in clinical research that perfectly integrates with our objective to support global trials that includes sites throughout Latin America," says Juan D. Gutierrez, President of SIPLAS Research Organization Inc. About Averion: Averion provides clinical trials support for biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. , pharmaceutical and medical device companies in the design, execution and reporting of clinical trials. Services include Program Planning, Study Design, Clinical Monitoring Clinical monitoring - Oversight and administrative efforts that monitor a participant's health during a clinical trial. The government and other clinical trial funding agencies require data and safety monitoring boards to oversee clinical trials. , Medical Monitoring, Data Management, Database Development, Biometrics, Medical Writing, Data Monitoring Committees A Data Monitoring Committee (DMC, sometimes also called Data Safety Monitoring Board or DSMB) is an independent group of experts who monitor patient safety and treatment efficacy data while a clinical trial is ongoing. , Compliance and Validation, and FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. Representation. Averion's corporate headquarters are located in Framingham, Massachusetts Framingham is a town in Middlesex County, Massachusetts. As of the 2000 census, the population was 66,910, making it the most populous town in New England. The 2005 population estimate is 65,598. . Visit Averion's website at www.averioninc.com. About SIPLAS RO: SIPLAS Research Organization is a specialty, technology-based CRO dedicated to conducting superior Phase II-IV clinical trials in the Andean region Andean region may refer to:
|
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion